These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 19303391)
1. Comparative removal of solvent and detergent viral inactivating agents from human intravenous immunoglobulin G preparations using SDR HyperD and C18 sorbents. Burnouf T; Sayed MA; Radosevich M; El-Ekiaby M Anal Biochem; 2009 Jun; 389(1):69-73. PubMed ID: 19303391 [TBL] [Abstract][Full Text] [Related]
2. Impact of Triton X-100 on alpha 2-antiplasmin (SERPINF2) activity in solvent/detergent-treated plasma. Burnouf T; Goubran HA; Radosevich M; Sayed MA; Gorgy G; El-Ekiaby M Biologicals; 2007 Oct; 35(4):349-53. PubMed ID: 17656111 [TBL] [Abstract][Full Text] [Related]
3. A minipool process for solvent-detergent treatment of cryoprecipitate at blood centres using a disposable bag system. Burnouf T; Goubran HA; Radosevich M; Sayed MA; Gorgy G; El-Ekiaby M Vox Sang; 2006 Jul; 91(1):56-62. PubMed ID: 16756602 [TBL] [Abstract][Full Text] [Related]
4. Resistance of vaccinia virus to inactivation by solvent/detergent treatment of blood products. Roberts P Biologicals; 2000 Mar; 28(1):29-32. PubMed ID: 10799053 [TBL] [Abstract][Full Text] [Related]
5. A process for solvent/detergent treatment of plasma for transfusion at blood centers that use a disposable-bag system. Burnouf T; Goubran HA; Radosevich M; Sayed MA; Gorgy G; El-Ekiaby M Transfusion; 2006 Dec; 46(12):2100-8. PubMed ID: 17176321 [TBL] [Abstract][Full Text] [Related]
6. Assessment of the impact of solvent/detergent treatment on the quality and potency of a whole IgG equine antivenom. Segura A; León G; Su CY; Gutiérrez JM; Burnouf T Biologicals; 2009 Oct; 37(5):306-12. PubMed ID: 19540775 [TBL] [Abstract][Full Text] [Related]
7. Virus inactivation by solvent/detergent treatment using Triton X-100 in a high purity factor VIII. Roberts PL Biologicals; 2008 Sep; 36(5):330-5. PubMed ID: 18674928 [TBL] [Abstract][Full Text] [Related]
8. Solvent-detergent filtered (S/D-F) fresh frozen plasma and cryoprecipitate minipools prepared in a newly designed integral disposable processing bag system. El-Ekiaby M; Sayed MA; Caron C; Burnouf S; El-Sharkawy N; Goubran H; Radosevich M; Goudemand J; Blum D; de Melo L; Soulié V; Adam J; Burnouf T Transfus Med; 2010 Feb; 20(1):48-61. PubMed ID: 19778318 [TBL] [Abstract][Full Text] [Related]
9. Removal of detergent and solvent from solvent-detergent-treated immunoglobulins. Trescec A; Simić M; Branović K; Gebauer B; Benko B J Chromatogr A; 1999 Aug; 852(1):87-91. PubMed ID: 10480233 [TBL] [Abstract][Full Text] [Related]
10. Extraction of Triton X-100 and its determination in virus-inactivated human plasma by the solvent--detergent method. Strancar A; Raspor P; Schwinn H; Schütz R; Josic D J Chromatogr A; 1994 Jan; 658(2):475-81. PubMed ID: 8118553 [TBL] [Abstract][Full Text] [Related]
11. Solvent/detergent treatment of platelet concentrates enhances the release of growth factors. Burnouf T; Tseng YH; Kuo YP; Su CY Transfusion; 2008 Jun; 48(6):1090-8. PubMed ID: 18373502 [TBL] [Abstract][Full Text] [Related]
12. Dengue virus inactivation by minipool TnBP/Triton X-45 treatment of plasma and cryoprecipitate. Burnouf T; Chou ML; Cheng LH; Li ZR; Wu YW; El-Ekiaby M; Tsai KH Vox Sang; 2013 Jan; 104(1):1-6. PubMed ID: 22758375 [TBL] [Abstract][Full Text] [Related]
13. TnBP⁄Triton X-45 treatment of plasma for transfusion efficiently inactivates hepatitis C virus. Chou ML; Burnouf T; Chang SP; Hung TC; Lin CC; Richardson CD; Lin LT PLoS One; 2015; 10(2):e0117800. PubMed ID: 25658612 [TBL] [Abstract][Full Text] [Related]
14. Preparation, purification and virus inactivation of intravenous immunoglobulin from human plasma. Aghaie A; Pourfatollah AA; Bathaie SZ; Moazzeni SM; Khorsand Mohammad Pour H; Banazadeh S Hum Antibodies; 2010; 19(1):1-6. PubMed ID: 20555125 [TBL] [Abstract][Full Text] [Related]
15. Virus inactivation in a factor VIII/VWF concentrate treated using a solvent/detergent procedure based on polysorbate 20. Roberts PL; Lloyd D; Marshall PJ Biologicals; 2009 Jan; 37(1):26-31. PubMed ID: 18848782 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of eco-friendly zwitterionic detergents for enveloped virus inactivation. Conley L; Tao Y; Henry A; Koepf E; Cecchini D; Pieracci J; Ghose S Biotechnol Bioeng; 2017 Apr; 114(4):813-820. PubMed ID: 27800626 [TBL] [Abstract][Full Text] [Related]
17. Inactivation of virus in intravenous immunoglobulin G using solvent/detergent treatment and pasteurization. Aghaie A; Pourfatollah AA; Bathaie SZ; Moazzeni SM; Khorsand Mohammad Pour H; Sharifi Z Hum Antibodies; 2008; 17(3-4):79-84. PubMed ID: 19029665 [TBL] [Abstract][Full Text] [Related]
18. Single-use technology for solvent/detergent virus inactivation of industrial plasma products. Hsieh YT; Mullin L; Greenhalgh P; Cunningham M; Goodrich E; Shea J; Youssef E; Burnouf T Transfusion; 2016 Jun; 56(6):1384-93. PubMed ID: 27125447 [TBL] [Abstract][Full Text] [Related]
19. Cloud point extraction of toxic eosin dye using Triton X-100 as nonionic surfactant. Purkait MK; Banerjee S; Mewara S; DasGupta S; De S Water Res; 2005 Oct; 39(16):3885-90. PubMed ID: 16143363 [TBL] [Abstract][Full Text] [Related]
20. Robustness of solvent/detergent treatment of plasma derivatives: a data collection from Plasma Protein Therapeutics Association member companies. Dichtelmüller HO; Biesert L; Fabbrizzi F; Gajardo R; Gröner A; von Hoegen I; Jorquera JI; Kempf C; Kreil TR; Pifat D; Osheroff W; Poelsler G Transfusion; 2009 Sep; 49(9):1931-43. PubMed ID: 19497061 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]